4 citations
,
November 2021 in “Journal of the European Academy of Dermatology and Venereology” This study observed that telogen effluvium is the most frequent and specific dermatological manifestation in patients with long COVID syndrome following severe SARS-CoV2 infection.
February 2025 in “The Open Dermatology Journal” In this study conducted at Afzalipour Hospital in Iran, researchers found a significant prevalence of alopecia, particularly resembling telogen effluvium, among COVID-19-recovered patients, with hair loss being more common in females and correlating with arterial oxygen saturation levels.
October 2023 in “Dermatology practical & conceptual” This study observed that among 120 patients recovering from COVID-19, severe diffuse hair loss typically began less than two months post-infection, with the majority of patients experiencing a severe degree of hair loss and positive hair pull tests, often alongside vitamin D deficiency.
June 2022 in “Journal of the turkish academy of dermatology” This study observed that the COVID-19 pandemic altered the distribution of dermatological diseases, with increased cases of conditions like scabies and telogen effluvium, while acne and psoriasis cases decreased.
August 2024 in “Journal of Research in Clinical Medicine” In this study, researchers observed that patients with COVID-19 can develop a variety of skin lesions, with maculopapular rash, telogen effluvium, and urticaria showing significant associations with both the timing of symptom onset and the severity of the disease.